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journal homepage: www.elsevier .com/locate/conctcEditorialWe are excited to launch the journal Contemporary Clinical Trials
Communications, an international peer reviewed open access sister
journal of Contemporary Clinical Trials. It is a fruit of numerous
discussions and surveys on a large number of trial practitioners
and researchers to cover all aspects of clinical trials, including,
but not limited to, design, conduct, analysis, regulation and ethics.
Contemporary Clinical Trials Communications is unique in that
it is outside the conﬁnes of disease speciﬁcations, it covers both
randomized and non-randomized clinical trials and it strives to
increase the transparency of medical research and reduce
publication bias. By publishing scientiﬁcally valid original research
ﬁndings irrespective of their perceived importance, signiﬁcance or
impact, the new journal strives to appeal to authorships and read-
erships from a wide range of disciplines including medicine, life
science, pharmaceutical science, biostatistics, epidemiology,
computer science, management science, behavioral science, and
bioethics.
The editorial team of Contemporary Clinical Trials Communica-
tions comprises leading experts from a wide range of disciplines
and from various regions, including Europe, North America, Southhttp://dx.doi.org/10.1016/j.conctc.2015.10.003
2451-8654/© 2015 Published by Elsevier Inc. This is an open access article under the CCAmerica and Asia Paciﬁc, where clinical trials have been frequently
conducted. On behalf of the Editorial team, we welcome your sub-
mission of articles on clinical trials.
It is the ultimate goal of Contemporary Clinical Trials Communica-
tions to disseminate advances in clinical trials timely and to
enhance the communication and collaboration within the global
clinical trials community that ultimately beneﬁts patients. We are
looking forward to achieving the goal through close interactions
among authors, reviewers, editorial members and readers.Zhezhen Jin, Editor-in-Chief*
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